Nail changes secondary to docetaxel chemotherapy : a case report

INTRODUCTION: Docetaxel is a chemotherapy agent used in the management of many neoplastic conditions. Various side effects are known. Nail changes are often under-recognised or attributed to other causes. CASE PRESENTATION: We report the case of a 66 year old gentleman who received docetaxel chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghafoor, Qamar, Chetiyawardana, Anula
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254642/
https://www.ncbi.nlm.nih.gov/pubmed/18226208
http://dx.doi.org/10.1186/1752-1947-2-24
_version_ 1782151212447039488
author Ghafoor, Qamar
Chetiyawardana, Anula
author_facet Ghafoor, Qamar
Chetiyawardana, Anula
author_sort Ghafoor, Qamar
collection PubMed
description INTRODUCTION: Docetaxel is a chemotherapy agent used in the management of many neoplastic conditions. Various side effects are known. Nail changes are often under-recognised or attributed to other causes. CASE PRESENTATION: We report the case of a 66 year old gentleman who received docetaxel chemotherapy for non-small cell lung cancer. He had nail changes as a complication of the treatment. CONCLUSION: Nail toxicity is a recognised side-effect of taxane chemotherapy agents and can often persist for many months after finishing the treatment. We would like to highlight this problem, so it can be considered as a differential diagnosis in the appropriate population.
format Text
id pubmed-2254642
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22546422008-02-27 Nail changes secondary to docetaxel chemotherapy : a case report Ghafoor, Qamar Chetiyawardana, Anula J Med Case Reports Case Report INTRODUCTION: Docetaxel is a chemotherapy agent used in the management of many neoplastic conditions. Various side effects are known. Nail changes are often under-recognised or attributed to other causes. CASE PRESENTATION: We report the case of a 66 year old gentleman who received docetaxel chemotherapy for non-small cell lung cancer. He had nail changes as a complication of the treatment. CONCLUSION: Nail toxicity is a recognised side-effect of taxane chemotherapy agents and can often persist for many months after finishing the treatment. We would like to highlight this problem, so it can be considered as a differential diagnosis in the appropriate population. BioMed Central 2008-01-28 /pmc/articles/PMC2254642/ /pubmed/18226208 http://dx.doi.org/10.1186/1752-1947-2-24 Text en Copyright © 2008 Ghafoor and Chetiyawardana; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ghafoor, Qamar
Chetiyawardana, Anula
Nail changes secondary to docetaxel chemotherapy : a case report
title Nail changes secondary to docetaxel chemotherapy : a case report
title_full Nail changes secondary to docetaxel chemotherapy : a case report
title_fullStr Nail changes secondary to docetaxel chemotherapy : a case report
title_full_unstemmed Nail changes secondary to docetaxel chemotherapy : a case report
title_short Nail changes secondary to docetaxel chemotherapy : a case report
title_sort nail changes secondary to docetaxel chemotherapy : a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254642/
https://www.ncbi.nlm.nih.gov/pubmed/18226208
http://dx.doi.org/10.1186/1752-1947-2-24
work_keys_str_mv AT ghafoorqamar nailchangessecondarytodocetaxelchemotherapyacasereport
AT chetiyawardanaanula nailchangessecondarytodocetaxelchemotherapyacasereport

Ejemplares similares